Ceribell, Inc. financial data

Symbol
CBLL on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
360 N. Pastoria Avenue, Sunnyvale, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 25, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Return On Equity 84.3 % +193%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 35.9M shares
Common Stock, Shares, Outstanding 35.9M shares +560%
Common Stock, Value, Issued 36K USD +620%
Weighted Average Number of Shares Outstanding, Basic 5.63M shares +5.45%
Weighted Average Number of Shares Outstanding, Diluted 5.63M shares +5.45%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 17.2M USD +48.1%
Cost of Revenue 2.18M USD +15.9%
Research and Development Expense 3.4M USD +47.1%
Selling and Marketing Expense 12.5M USD +30.6%
General and Administrative Expense 9.03M USD +80.9%
Operating Income (Loss) -9.94M USD -38.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -10.4M USD -47.7%
Net Income (Loss) Attributable to Parent -40.5M USD -37.3%
Earnings Per Share, Basic -1.85 USD/shares -40.2%
Earnings Per Share, Diluted -1.85 USD/shares -40.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 194M USD +463%
Accounts Receivable, after Allowance for Credit Loss, Current 10.9M USD +36.7%
Inventory, Net 6.94M USD +18.2%
Assets, Current 217M USD +318%
Property, Plant and Equipment, Net 2.31M USD +46.7%
Operating Lease, Right-of-Use Asset 2.13M USD -1.3%
Other Assets, Noncurrent 2.19M USD +10.3%
Assets 225M USD +283%
Accounts Payable, Current 1.14M USD +56.1%
Employee-related Liabilities, Current 4.39M USD +40.2%
Accrued Liabilities, Current 10.1M USD +33.3%
Contract with Customer, Liability, Current 97K USD -52.9%
Liabilities, Current 13M USD -39.9%
Contract with Customer, Liability, Noncurrent 30K USD -31.8%
Operating Lease, Liability, Noncurrent 1.31M USD -21.6%
Other Liabilities, Noncurrent 356K USD -19.3%
Liabilities 34.2M USD +44.1%
Retained Earnings (Accumulated Deficit) -167M USD -32%
Stockholders' Equity Attributable to Parent 191M USD
Liabilities and Equity 225M USD +283%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 500M shares +557%
Common Stock, Shares, Issued 35.9M shares +560%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 194M USD +463%
Deferred Tax Assets, Valuation Allowance 42.8M USD +28.9%
Deferred Tax Assets, Gross 45.1M USD +29%
Operating Lease, Liability 2.4M USD +1.31%
Depreciation 79K USD -12.2%
Lessee, Operating Lease, Liability, to be Paid 2.58M USD
Property, Plant and Equipment, Gross 4.01M USD +36%
Operating Lease, Liability, Current 1.09M USD +56.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.26M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 1.22M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure +16%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 176K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 107K USD
Deferred Tax Assets, Operating Loss Carryforwards 34.8M USD +20.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares
Unrecognized Tax Benefits 556K USD +17.1%
Operating Lease, Payments 204K USD +3.03%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 1.38M USD +116%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%